Immunome, Inc. · NASDAQ:IMNM
Enavate Sciences Gp, LLC reported a 4.30% stake in Immunome, Inc. (Schedule 13D/A)
Event Dec 18, 2025 · Filed Dec 22, 2025
Enavate Sciences Gp, LLC reported a 4.30% stake in Immunome, Inc., 4,768,583 shares, with active intent on Dec 18, 2025. Filed Dec 22, 2025 (Schedule 13D/A).
- Stake
- 4.30%
- Shares
- 4,768,583
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Enavate Sciences GP, LLC | 4.30% | 4,768,583 |
| Immunome Aggregator, LP | 4.30% | 4,768,583 |
Source
Related
- Immunome, Inc.
- Enavate Sciences Gp, LLC
- Immunome, Inc. shareholders
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026